PSEN1 and neoplasm: Significant reduction in tumor burden was observed in mice treated with chitosan nanoparticles/PS1 siRNA compared to the group treated with chitosan nanoparticles/control siRNA following 3 weeks of therapy (Figure 2C) (p < 0.05).